Vázquez, X.; Forcelledo, L.; Balboa-Palomino, S.; Fernández, J.; Rodicio, M.R.
Nosocomial Pneumonia Caused in an Immunocompetent Patient by the Emergent Monophasic ST34 Variant of Salmonella enterica Serovar Typhimurium: Treatment-Associated Selection of Fluoroquinolone and Piperacillin/Tazobactam Resistance. Antibiotics 2022, 11, 303.
https://doi.org/10.3390/antibiotics11030303
AMA Style
Vázquez X, Forcelledo L, Balboa-Palomino S, Fernández J, Rodicio MR.
Nosocomial Pneumonia Caused in an Immunocompetent Patient by the Emergent Monophasic ST34 Variant of Salmonella enterica Serovar Typhimurium: Treatment-Associated Selection of Fluoroquinolone and Piperacillin/Tazobactam Resistance. Antibiotics. 2022; 11(3):303.
https://doi.org/10.3390/antibiotics11030303
Chicago/Turabian Style
Vázquez, Xenia, Lorena Forcelledo, Salvador Balboa-Palomino, Javier Fernández, and MarÃa Rosario Rodicio.
2022. "Nosocomial Pneumonia Caused in an Immunocompetent Patient by the Emergent Monophasic ST34 Variant of Salmonella enterica Serovar Typhimurium: Treatment-Associated Selection of Fluoroquinolone and Piperacillin/Tazobactam Resistance" Antibiotics 11, no. 3: 303.
https://doi.org/10.3390/antibiotics11030303
APA Style
Vázquez, X., Forcelledo, L., Balboa-Palomino, S., Fernández, J., & Rodicio, M. R.
(2022). Nosocomial Pneumonia Caused in an Immunocompetent Patient by the Emergent Monophasic ST34 Variant of Salmonella enterica Serovar Typhimurium: Treatment-Associated Selection of Fluoroquinolone and Piperacillin/Tazobactam Resistance. Antibiotics, 11(3), 303.
https://doi.org/10.3390/antibiotics11030303
